Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in the...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science (PLoS)
2019-07-01
|
| Col·lecció: | PLoS Neglected Tropical Diseases |
| Accés en línia: | https://doi.org/10.1371/journal.pntd.0007595 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
